[{"会社名":"キョーリン製薬ホールディングス(株)【4569】","証券コード":"4569","　":"前期","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月9日","決算月数":"12か月","売上高":"111,400百万円","営業利益":"17,607百万円","経常利益":"18,281百万円","当期利益":"12,025百万円","EPS（一株当たり利益）":"160.95円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,844.61円","総資産":"169,378百万円","自己資本":"137,821百万円","資本金":"700百万円","有利子負債":"1,920百万円","自己資本比率":"81.4%","ROA（総資産利益率）":"7.41%","ROE（自己資本利益率）":"9.01%","総資産経常利益率":"11.27%"},{"会社名":"キョーリン製薬ホールディングス(株)【4569】","証券コード":"4569","　":"2期前","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月9日","決算月数":"12か月","売上高":"107,031百万円","営業利益":"17,948百万円","経常利益":"18,676百万円","当期利益":"12,422百万円","EPS（一株当たり利益）":"166.25円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,727.86円","総資産":"154,968百万円","自己資本":"129,099百万円","資本金":"700百万円","有利子負債":"1,774百万円","自己資本比率":"83.3%","ROA（総資産利益率）":"8.26%","ROE（自己資本利益率）":"10.05%","総資産経常利益率":"12.42%"},{"会社名":"キョーリン製薬ホールディングス(株)【4569】","証券コード":"4569","　":"3期前","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月9日","決算月数":"12か月","売上高":"103,232百万円","営業利益":"14,464百万円","経常利益":"15,275百万円","当期利益":"9,231百万円","EPS（一株当たり利益）":"123.54円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,581.94円","総資産":"145,673百万円","自己資本":"118,201百万円","資本金":"700百万円","有利子負債":"3,475百万円","自己資本比率":"81.1%","ROA（総資産利益率）":"6.30%","ROE（自己資本利益率）":"8.03%","総資産経常利益率":"10.43%"}]